We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Dulaglutide slowed the eGFR decline in patients with type 2 diabetes and CKD stage 3 to 4.
No takes yet. Share an insight, caveat, or question.
Tsuchida et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: